Beyond The Lab - How Medicines Become Successful Businesses | Jane Gonnerman
We tend to think that a new medicine's journey begins in the laboratory and ends when the FDA approves it. But there's an enormous part of that journey that most people never see: Who decides which medicines a company should acquire? Which ones are worth billions of dollars? How do you turn an approved drug into a successful commercial product - and ultimately get it into the hands of patients? Today we're going behind the scenes of that process. Jane Gonnerman is Executive Vice President of Strategy and Corporate Development at Collegium Pharmaceutical ( https://www.collegiumpharma.com/ ), a…